parthenolide has been researched along with Cholangiocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DG; Kim, IH; Kim, JH; Lee, MJ; Yu, GR; Yun, BR | 1 |
| Kim, DG; Kim, JH; Kim, YT; Lee, SO; Liu, L; You, KR | 1 |
2 other study(ies) available for parthenolide and Cholangiocarcinoma
| Article | Year |
|---|---|
Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cholangiocarcinoma; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Heme Oxygenase-1; Humans; Lactones; NF-E2-Related Factor 2; Protein Kinase C-alpha; RNA, Small Interfering; Sesquiterpenes; Signal Transduction | 2010 |
Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Cytochromes c; Drug Resistance, Neoplasm; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Membrane Potentials; Mitochondria; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sesquiterpenes; Tumor Suppressor Protein p53 | 2005 |